Guru Sonpavde
Guru P. Sonpavde/adventhealthcancerinstitute.com

Guru Sonpavde: Adjuvant Therapy in Bladder Cancer – IBCU 2025

Guru Sonpavde, Director of the bladder cancer program at Dana-Farber Cancer Institute, shared a post on X:

“Bladder cancer adjuvant therapy: pleased to share thoughts from my recent lecture at the International bladder cancer update IBCU meeting 2025 – from  AdventHealth Central Florida Cancer Institute, Orlando, Florida.”

Guru Sonpavde: Adjuvant Therapy in Bladder Cancer – IBCU 2025

More posts featuring Guru P. Sonpavde on OncoDaily.